• FDA Volara Ventilator Warning Upgraded to Full Recall

    6 days ago - By Medscape

    The at-home ventilator and breathing treatment may cause injury or death, a new FDA alert warns.
    News Alerts
    Read more ...

     

  • FDA approves abbreviated new drug application for oral anxiety treatment

    FDA approves abbreviated new drug application for oral anxiety treatment

    6 days ago - By Healio

    ANI Pharmaceuticals Inc. has received FDA approval of its abbreviated new drug application for clorazepate dipotassium tablets, according to a company press release.
    ANI stated that this is a generic version of Tranxene , which is indicated for managing anxiety disorders, according to the FDA package insert.
    "We continue to strengthen our base business with new product launches,” ANI President and CEO Nikhil Lalwani, said in the release. “The imminent launch and commercialization of clorazepate dipotassium tablets is another example of our ongoing
    Read more ...